Our Entrepreneurs

Gabriel Fernández

Laboratorios Clausen

Gabriel Fernández Gabriel Fernández

Impact metric

307% growth in jobs since selection
“I saw an opportunity to advance cancer research in Uruguay.
Country
Uruguay
Industry
Prof. Services
Employees
137
partner
Leonardo Olivera
Website

Company Snapshot

Laboratorios Clausen is the first and only Uruguayan biotech firm to develop an entirely new molecule. Thrombopoetin, a human protein that stimulates the production of platelets, was patented in 1998. Today it is used in treatments for cancer and blood coagulation disorders. To elevate Laboratorios Clausen to the next level, Gabriel and Leonardo have constructed a state-of-the-art production facility that is one of only three EMEA Certified facilities in Latin America. Clausen was the subject of a Universidad ORT Uruguay case study.

Since selection by Endeavor, company revenues have grown by 256%.

Endeavor and Rinquepharma

Gabriel and Leo have benefited from local strategic mentorship, support in strengthening their patent applications, custom workshops on management issues, and introductions to local business leaders to help foster the country’s biotech industry. They also benefited from the Ernst & Young Fellows program, and the eMBA program which developed a business plan for new patents and methods of seeking capital.

The Entrepreneurs have demonstrated commitment by participating as speakers at Endeavor events, and screening candidates.

From the Entrepreneurship Blog

Events

Endeavor's Linda Rottenberg Highlights the Inclusive Power of Entrepreneurship for WEF 2015

January 26th, 2015 — by admin

As part of the World Economic Forum’s annual gathering in Davos, Linda Rottenberg, Endeavor co-founder and CEO, published an article assessing the state of inclusive entrepreneurship worldwide. The ar…

Read more

In the news

Endeavor's Linda Rottenberg Highlights the Inclusive Power of Entrepreneurship for WEF 2015

January 26th, 2015 — by admin

As part of the World Economic Forum’s annual gathering in Davos, Linda Rottenberg, Endeavor co-founder and CEO, published an article assessing the state of inclusive entrepreneurship worldwide. The ar…

Read more

Contact us

Press center

Community

Newsletter Sign Up